Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation
Author(s):
Bodegraven, A.A. van; Bravenboer, N.; Witte, B.I.; Dijkstra, G.; Woude, C.J. van der; Stokkers, P.C.M.; Russel, M.G.; Oldenburg, B.; Pierik, M.; Roos, J.C.; Hogezand, R.A. van; Dik, V.K.; Oostlander, A.E.; Netelenbos, J.C.; Langerijt, L. van de; Hommes, D.W.; Lips, P.; Dutch Initiative Crohn Colitis ICC
